In order to accomplish reliable and valid research into the characteristics and mechanisms of Alzheimer's disease (AD) and related dementias, it is imperative to have data available from a well- characterized cohort of patients, with longitudinal follow-up to provide information on the course of the disease. The cohort should have a broad range of levels of education and socioeconomic status, as well as racial diversity. The cohort should contain patients with varying levels of disease severity, in order to provide subjects for studies requiring mild, moderate, or severe AD. Further, a system must be in place for the prospective entry of new patients and age-equivalent control subjects into a registry to be available for future research studies. The Clinical Core of the Alzheimer's Disease Research Center fulfills these functions for the University of Pittsburgh ADRC. The purpose of this Clinical Core is to provide evaluation and follow-up to patients and control subjects enrolled through the Memory Disorders Clinic and followed in the ADRC Registry. Specifically, the Core provides a detailed evaluation of all patients/control subjects at study entry, and annual re-evaluations until the patient/subject drops from the project or dies. The Core also strives towards maximal participation in the autopsy program of the ADRC by providing longitudinal follow-up to these patients and control subjects. The Clinical Core is also responsible for providing clinical data, research subjects (patients and controls), and technical and scientific leadership for support of new and ongoing research at the University of Pittsburgh ADRC and associated local, regional, national, and international studies. Finally, the ADRC will continue outreach programs developed during the past three years to provide care and support for members of the medically underserved inner-city and rural populations of Western Pennsylvania. The ADRC established a satellite clinic, the Alzheimer Outreach Center, in the predominantly African American Hill District of Pittsburgh during the current funding period. Patients seen in the AOC Clinic evaluated and enrolled in the ADRC Registry in the same manner as the patients at the University Memory Disorders Clinic, increasing the number of African American controls and patients in the Registry. Special programs to educate the African American Community on the value of autopsy are part of this program. External confirmation of the accuracy of the clinical diagnosis of AD is vital to assure that the diagnostic procedures employed by the Clinical Core are appropriate. Autopsy confirmation of a clinical diagnosis of Probable AD was greater than 90% for all cases from the ADRC coming to autopsy since inception of the Center.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
3P50AG005133-16S2
Application #
6218654
Study Section
Project Start
1999-08-15
Project End
2000-04-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
16
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Type
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Tudorascu, Dana L; Minhas, Davneet S; Lao, Patrick J et al. (2018) The use of Centiloids for applying [11C]PiB classification cutoffs across region-of-interest delineation methods. Alzheimers Dement (Amst) 10:332-339
Lancour, Daniel; Naj, Adam; Mayeux, Richard et al. (2018) One for all and all for One: Improving replication of genetic studies through network diffusion. PLoS Genet 14:e1007306
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021
DeKosky, Steven T; Jaffee, Michael; Bauer, Russell (2018) Long-term Mortality in NFL Professional Football Players: No Significant Increase, but Questions Remain. JAMA 319:773-775
Snitz, Beth E; Wang, Tianxiu; Cloonan, Yona Keich et al. (2018) Risk of progression from subjective cognitive decline to mild cognitive impairment: The role of study setting. Alzheimers Dement 14:734-742
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Fowler, Nicole R; Shaaban, C Elizabeth; Torke, Alexia M et al. (2018) ""I'm Not Sure We Had A Choice"": Decision Quality and The Use of Cardiac Implantable Electronic Devices In Older Adults With Cognitive Impairment. Cardiol Cardiovasc Med 2:10-26
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27
Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827

Showing the most recent 10 out of 667 publications